Citigroup’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43.6K Buy
5,937
+1,084
+22% +$7.97K ﹤0.01% 4109
2025
Q1
$37.5K Sell
4,853
-546
-10% -$4.22K ﹤0.01% 4188
2024
Q4
$65.3K Buy
5,399
+323
+6% +$3.91K ﹤0.01% 4162
2024
Q3
$63.7K Buy
5,076
+3,514
+225% +$44.1K ﹤0.01% 4166
2024
Q2
$18.6K Sell
1,562
-10,606
-87% -$127K ﹤0.01% 4285
2024
Q1
$213K Buy
12,168
+4,420
+57% +$77.3K ﹤0.01% 3267
2023
Q4
$199K Buy
+7,748
New +$199K ﹤0.01% 3190
2022
Q3
Sell
-67
Closed -$1K 5142
2022
Q2
$1K Buy
+67
New +$1K ﹤0.01% 5216
2021
Q2
Sell
-649
Closed -$25K 5518
2021
Q1
$25K Sell
649
-280
-30% -$10.8K ﹤0.01% 4443
2020
Q4
$44K Buy
929
+788
+559% +$37.3K ﹤0.01% 4172
2020
Q3
$5K Sell
141
-165
-54% -$5.85K ﹤0.01% 4659
2020
Q2
$13K Buy
+306
New +$13K ﹤0.01% 4511
2019
Q4
Sell
-179
Closed -$7K 5137
2019
Q3
$7K Sell
179
-591
-77% -$23.1K ﹤0.01% 4679
2019
Q2
$43K Buy
770
+378
+96% +$21.1K ﹤0.01% 4192
2019
Q1
$24K Sell
392
-69
-15% -$4.22K ﹤0.01% 4439
2018
Q4
$28K Buy
461
+26
+6% +$1.58K ﹤0.01% 4257
2018
Q3
$35K Buy
435
+118
+37% +$9.49K ﹤0.01% 4288
2018
Q2
$28K Buy
+317
New +$28K ﹤0.01% 4241
2017
Q1
Sell
-1
Closed 4847
2016
Q4
$0 Buy
+1
New ﹤0.01% 4893
2016
Q1
Sell
-1
Closed 5428
2015
Q4
$0 Buy
+1
New ﹤0.01% 5493
2015
Q1
Sell
-1
Closed -$2K 5537
2014
Q4
$2K Buy
+1
New +$2K ﹤0.01% 5219
2014
Q3
Sell
-2
Closed -$5K 5251
2014
Q2
$5K Sell
2
-4
-67% -$10K ﹤0.01% 4823
2014
Q1
$21K Sell
6
-10
-63% -$35K ﹤0.01% 4457
2013
Q4
$51K Buy
16
+1
+7% +$3.19K ﹤0.01% 4149
2013
Q3
$61K Sell
15
-1
-6% -$4.07K ﹤0.01% 3522
2013
Q2
$53K Buy
+16
New +$53K ﹤0.01% 3736